Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold

• Status: Completed
• Trial end date: 2007-04-01

Summary

The aim of this study is to characterize the time profile of the decongestant properties of xylometazoline and to investigate its effect on sleep, general well-being and smell/taste.

• Phase: Phase 3

Details

• Lead Sponsor: Novartis
• Treatments: Ephedrine; Nasal Decongestants; Pseudoephedrine; Xylometazoline